Atreca, Inc. (BCEL)
Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA.
Address
835 INDUSTRIAL ROAD,
SAN CARLOS, CA 94070
Founded
2010
Number of Employees
90
Website
http://www.atreca.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)